A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Mise à jour : Il y a 4 ans
Référence : NCT00134264

Femme et Homme

Extrait

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To demonstrate if torcetrapib/atorvastatin can reduce the risk for major cardiovascular disease events, when compared to atorvastatin alone, in patients with coronary heart disease or risk equivalents


Critère d'inclusion

  • Coronary Disease ,Diabetes Mellitus


Liens